Prognostic significance of differentially expressed miRNAs in esophageal cancer.
Hu
Yuxin
Y
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX77030, USA.
Correa
Arlene M
AM
Hoque
Ashraful
A
Guan
Baoxiang
B
Ye
Fei
F
Huang
Jie
J
Swisher
Stephen G
SG
Wu
Tsung Teh
TT
Ajani
Jaffer A
JA
Xu
Xiao-Chun
XC
D000230:Adenocarcinoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015152:Blotting, Northern; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D045744:Cell Line, Tumor; D004938:Esophageal Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D053208:Kaplan-Meier Estimate; D019394:Ki-67 Antigen / Q000378:metabolism; D008297:Male; D035683:MicroRNAs / Q000235:genetics*; D008875:Middle Aged; D015999:Multivariate Analysis; D011379:Prognosis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D046888:Tissue Array Analysis
D019394:Ki-67 Antigen; C505362:MIRN16 microRNA, human; C546086:MIRN30b microRNA, human; C522425:MIRN34 microRNA, human; D035683:MicroRNAs